Back to search

An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer.

Data up to Jan 2025

Published2000
Citations111
References18

Total Citations Per Year

Abstract

References (18)

Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer

1989 • 6,734 citations

Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors

1992 • 3,344 citations

PIK3CA is implicated as an oncogene in ovarian cancer

1999 • 1,170 citations

Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas

1995 • 831 citations

Overexpression and mutation of p53 in epithelial ovarian cancer.

1991 • 464 citations

Genetic analysis of benign, low-grade, and high-grade ovarian tumors.

1995 • 299 citations

NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas

1999 • 298 citations

Mutations of the E–cadherin gene in human gynecologic cancers

1994 • 280 citations

Spectrum of Mutation and Frequency of Allelic Deletion of the p53 Gene in Ovarian Cancer

1993 • 184 citations

Molecular Cloning of Differentially Expressed Genes in Human Epithelial Ovarian Cancer

1994 • 183 citations

Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma.

1993 • 176 citations

Identification of two candidate tumor suppressor genes on chromosome 17p13.3.

1996 • 146 citations

SPARC, an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cells.

1996 • 135 citations

c-myc amplification in ovarian cancer

1990 • 127 citations

Identification of a gene containing zinc-finger motifs based on lost expression in malignantly transformed rat ovarian surface epithelial cells.

1997 • 118 citations

Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas.

1993 • 97 citations

Loss of heterozygosity on chromosome 5q in ovarian cancer is frequently accompanied by TP53 mutation and identifies a tumour suppressor gene locus at 5q13.1-21

1996 • 52 citations

First experience with FGF-3 (INT-2) amplification in women with epithelial ovarian cancer

1993 • 29 citations

Cited By (0)

Loading...
An approach to analysis of large-scale correlations between genome changes and clinical… (2000) – PubMed | Metascience Observatory Explorer